FDA approves Kura and Kyowa Kirin’s drug for form of acute myeloid leukemianews2025-11-13T19:58:31+00:00November 13th, 2025|Endpoints News|
Law to end government shutdown also seeks to accelerate prescription-to-OTC switchesnews2025-11-13T19:35:40+00:00November 13th, 2025|Endpoints News|
FDA announces new regulatory pathway for personalized rare disease therapiesnews2025-11-12T22:00:19+00:00November 12th, 2025|Endpoints News|
Pazdur vs. Prasad: Can the CDER-CBER dynamic change under new leadership?news2025-11-12T20:37:57+00:00November 12th, 2025|Endpoints News|
FDA taps Richard Pazdur as new CDER director after Tidmarsh’s resignationnews2025-11-11T21:51:07+00:00November 11th, 2025|Endpoints News|
FDA seeks to remove warnings from labels of hormone therapies for menopausenews2025-11-10T20:21:16+00:00November 10th, 2025|Endpoints News|
CMS unveils new Medicaid drug payment modelnews2025-11-07T20:56:28+00:00November 7th, 2025|Endpoints News|
FDA says it raised concerns about Biohaven’s ataxia study several times since it was proposednews2025-11-07T20:08:07+00:00November 7th, 2025|Endpoints News|
FDA approves J&J’s Darzalex for smoldering multiple myelomanews2025-11-06T20:20:50+00:00November 6th, 2025|Endpoints News|
Makary pushes bounds of FDA commissioner role on prices, drug reviews and personnelnews2025-11-06T20:08:18+00:00November 6th, 2025|Endpoints News|
